Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 175.13B | 166.67B | 107.12B | 134.98B | 35.92B | 29.10B |
Gross Profit | 46.18B | 41.16B | 22.70B | 12.11B | 10.70B | 8.77B |
EBITDA | 76.69B | 74.84B | 45.19B | 43.86B | 13.03B | 11.66B |
Net Income | 23.24B | 23.52B | 12.55B | 6.88B | 5.03B | 4.50B |
Balance Sheet | ||||||
Total Assets | 418.12B | 344.28B | 247.08B | 101.26B | 70.68B | 51.50B |
Cash, Cash Equivalents and Short-Term Investments | 113.88B | 77.86B | 58.85B | 30.91B | 18.68B | 12.56B |
Total Debt | 150.71B | 104.34B | 84.08B | 53.85B | 36.78B | 21.59B |
Total Liabilities | 208.29B | 157.31B | 124.85B | 70.37B | 48.12B | 30.71B |
Stockholders Equity | 209.83B | 186.97B | 122.25B | 30.89B | 22.56B | 20.78B |
Cash Flow | ||||||
Free Cash Flow | 15.68B | 44.31B | 17.64B | 11.07B | 29.80B | 5.31B |
Operating Cash Flow | 70.40B | 75.01B | 60.24B | 25.15B | 19.95B | 13.09B |
Investing Cash Flow | -32.69B | -48.86B | -30.18B | -19.65B | -9.14B | -6.78B |
Financing Cash Flow | 18.93B | -9.78B | 9.77B | 3.39B | -3.94B | -4.27B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $5.39B | 12.82 | 6.74% | 3.85% | 14.09% | -11.43% | |
74 Outperform | $8.99B | 10.16 | 11.08% | 4.39% | -4.13% | 4.96% | |
71 Outperform | $4.67B | 8.75 | 28.10% | 7.44% | -0.91% | 11.25% | |
71 Outperform | $6.46B | 18.09 | 10.19% | 2.00% | -1.52% | 4874.58% | |
64 Neutral | $5.46B | ― | -0.84% | ― | -3.48% | -169.60% | |
62 Neutral | €3.67B | 3.64 | 4.45% | 4.92% | 5.39% | -160.72% | |
55 Neutral | $3.84B | 18.83 | 3.99% | ― | -12.77% | 40.80% |